WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 149 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $67,000 | -99.9% | 1,451 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $99,445,000 | -11.5% | 2,301,433 | -13.4% | 0.62% | -2.7% |
| Q2 2015 | $112,329,000 | +15.3% | 2,658,055 | +5.8% | 0.64% | +12.7% |
| Q1 2015 | $97,404,000 | +23.5% | 2,511,696 | +7.3% | 0.57% | +18.0% |
| Q4 2014 | $78,846,000 | -1.9% | 2,341,716 | +2.1% | 0.48% | +1.9% |
| Q3 2014 | $80,339,000 | +10.7% | 2,294,086 | +3.9% | 0.47% | +12.4% |
| Q2 2014 | $72,587,000 | +89.4% | 2,208,986 | +112.5% | 0.42% | +65.1% |
| Q1 2014 | $38,315,000 | -3.6% | 1,039,486 | +0.3% | 0.26% | -7.9% |
| Q4 2013 | $39,757,000 | +52.2% | 1,035,886 | +8.6% | 0.28% | +44.3% |
| Q3 2013 | $26,128,000 | +89.4% | 953,586 | +45.2% | 0.19% | +81.1% |
| Q2 2013 | $13,794,000 | – | 656,880 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coupland Cardiff Asset Management LLP | 448,361 | $15,096,000 | 21.12% |
| Sloane Robinson LLP | 107,400 | $3,616,000 | 6.28% |
| Sensato Investors LLC | 327,754 | $11,035,000 | 3.26% |
| Grandeur Peak Global Advisors, LLC | 388,810 | $13,091,000 | 2.94% |
| GRATRY & Co LLC | 205,800 | $7,899,000 | 2.59% |
| THOMAS WHITE INTERNATIONAL LTD | 464,926 | $15,654,000 | 2.15% |
| COMGEST GLOBAL INVESTORS S.A.S. | 1,819,980 | $61,279,000 | 1.87% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,169,686 | $39,383,000 | 1.64% |
| Ninety One North America, Inc. | 133,372 | $4,491,000 | 1.32% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 87,560 | $2,948,000 | 1.27% |